Section Arrow
SSII.NASDAQ
- SS Innovations International Inc
Quotes are at least 15-min delayed:2025/06/28 14:56 EDT
Last
 5.77
-0.77 (-11.77%)
Day High 
6.51 
Prev. Close
6.54 
1-M High
11.87 
Volume 
110.71K 
Bid
5.69
Ask
5.8
Day Low
5.71 
Open
6.51 
1-M Low
3.015 
Market Cap 
1.27B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 4.97 
20-SMA 5.22 
50-SMA 7.81 
52-W High 22.42 
52-W Low 0.32 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.08/--
Enterprise Value
1.27B
Balance Sheet
Book Value Per Share
0.21
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
20.65M
Operating Revenue Per Share
0.02
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
AMIXAutonomix Medical Inc2.01+0.76+60.80%-- 
NAOVNanoVibronix Inc1.17+0.3009+34.62%-- 
BFLYButterfly Network1.96-0.06-2.97%-- 
BBLGBone Biologics Corp4.58+0.42+10.10%0.08PE
BSXBoston Scientific Corp106.53+1.95+1.86%76.05PE
Quotes are at least 15-min delayed:2025/06/28 14:56 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.